Published on 14 Mar 2024 on Simply Wall St. via Yahoo Finance
HLS Therapeutics Inc. (TSE:HLS) stock most popular amongst retail investors who own 40%, while hedge...
Key Insights
Significant control over HLS Therapeutics by retail investors implies that the general public has more power to influence management and governance-related decisionsThe top 4 shareholders own 58% of the company 12% of HLS Therapeutics is held by Institutions
To get a sense of who is truly in control of HLS Therapeutics Inc. (TSE:HLS), it is important to understand the ownership structure of the business. And the group that holds the biggest piece of the pie are retail investors with 40% ownership. Put another way, the group faces the maximum upside potential (or downside risk).